Skip to main content

Table 2 Compliance with study medication (total course duration up to 14 days)

From: Pelargonium sidoides root extract for the treatment of acute cough due to lower respiratory tract infection in adults: a feasibility double-blind, placebo-controlled randomised trial

  Liquid Kaloba® (n = 27) Liquid placebo (n = 25) Tablet Kaloba® (n = 16) Tablet placebo (n = 20) All participants
Stopped in week 1 4/27 (14.8%) 5/25 (20.0%) 3/16 (18.8%) 2/20 (10.0%) 14/88 (15.9%)
Stopped in week 2 14/24 (58.3%) 14/20 (70.0%) 9/16 (56.3%) 15/21 (71.4%) 52/81 (64.2%)
Stopped in week 1 but still experienced moderately bad symptoms 2/17 (11.8%) 0/16 (0.0%) 1/9 (11.1%) 1/11 (9.1%) 4/53 (7.5%)
Stopped in week 2 but still experienced moderately bad symptoms 5/9 (55.6%) 6/9 (66.7%) 0/2 (0.0%) 4/7 (57.1%) 15/27 (55.6%)
Stopped in week 1 but had not recovered from all symptoms 2/20 (10.0%) 2/20 (10.0%) 1/14 (7.1%) 2/17 (11.8%) 7/71 (9.9%)
Stopped in week 2 but had not recovered from all symptoms 5/10 (50.0%) 6/10 (60.0%) 1/8 (12.5%) 6/10 (60.0%) 18/38 (47.4%)
Median (IQR) doses taken in week 1 20 (17,21) 18.5 (17,20) 19 (18,21) 19 (18, 21) 19 (18,21)
 ➙Morning 6 (6,7) 6 (5,6) 6 (6,7) 6 (6,7) 6 (6,7)
 ➙Afternoon 7 (5,7) 6 (5,7) 7 (6,7) 6.5 (5,7) 7 (5,7)
 ➙Evening 7 (7,7) 7 (6,7) 7 (6,7) 7 (6,7) 7 (6,7)
\